Concept Life Sciences biology team has first-hand industry experience in the discovery of new drugs across a broad range of therapeutic areas and biological target classes. We develop, optimize and validate cellular, biochemical and biophysical assays throughout the whole drug discovery process and deliver high-quality, consistent, cost-effective assay data to our clients with an emphasis on fast and efficient turnaround times.
Industry-standard and innovative technologies
Concept’s biology department offers a wide range of biochemical, biophysical and cellular assays using both industry-standard and innovative technologies to support drug discovery projects from target discovery to lead optimization.
Our biology team has proven expertise in choosing the right assay for target identification and validation, assay development, screening, hit validation, hit-to-lead, selectivity profiling, and lead optimization to enable the successful identification of candidate compounds/biologics for further development.
The majority of our highly experienced in vitro pharmacology scientists have over 15 years of drug discovery research expertise across a wide variety of therapeutic areas and target types.
Working collaboratively at each stage of the drug discovery pipeline
We develop, optimize and validate cellular, biochemical and biophysical assays to determine for example, the structure-activity relationship (SAR) and compound mechanism of action (MOA).
The biology department is dedicated to working collaboratively at each stage of the drug discovery pipeline and place a high value on client communication during all phases of a study. Our clients interact directly with bench biologists and immunologists, and work collaboratively with us to ensure the best possible outcome for their drug discovery program.